Reconstructing disease dynamics for mechanistic insights and clinical benefit
Navigating Drug Development: CytoReason’s Disease Model Platform
Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs
Making Clinical Trials Better for Everyone in 2023
Roundtable: What do you view as the most disruptive or transformational technology or development on the horizon?
Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances
Technology diffusion strategies for CIOs and the VC mindset
Sanofi extends cooperation with Israel’s CytoReason for bowel disease drug discovery
Follow the Money: University of Chicago Funds Biotech Accelerator, Breakthrough Tankless Inhaled Nitric Oxide Delivery System, More
Sanofi, CytoReason expand AI deal into IBD
